The synthesis of (4 or 5)-aryl-2-aroyl-1H-imidazoles and 2-hydroxy-3,6-diarylpyrazines from aryl methyl ketones via a cascade process of DMSO-HBr oxidation and Debus reaction was investigated. Owing to the simple starting materials, mild conditions, easy operation, high bioactivity of imidazole and pyrazine derivatives, this protocol has great potential in medicinal chemistry.
Introduction
Imidazole moiety exists widely in biological products and important chemical blocks, such as essential amino acid histidine, hormone histamine, antifungal drug nitroimidazoles, the sedative midazolam and so on. 1, 2 Among the big family of imidazole derivatives, (4 or 5)-aryl-2-aryloyl-(1H)-imidazoles (AAIs) exhibit many special properties. For example, topsentin ( Figure 1 ) is a bis-indole alkaloid isolated from the Mediterranean sponge Topsentia genitrix. 3 Topsentin derivatives have been detected to have antitumor and antiviral activities. According to the literature, the product of 1a had two isomeric 2-aryloylimidazoles 2a and 2a'. 28 So in this paper, all yields of AAIs referred to the yields of the two isomers. Most ammonium salts were less active than aqueous ammonia in this process (Table 1, entries 1-7) . So aqueous ammonia became the best choice. A higher conversion rate was observed when the reaction was carried out under low temperature (Table 1 , entries 7-10). Ultimately, optimal conditions were identified, that was, 1 mmol acetophenone and 1 mL HBr were mixed and stirred in 1 mL DMSO at 55 ºC for 10-12 h, then conducted with 1 mL aqueous ammonia at 0-5 o C and stirred for 1 h. Having the optimal reaction conditions established, we explored the scope of this cascade reaction. An array of aryl methyl ketones were examined. The results were shown in Table 2 . Aromatic methyl ketones 1a-i bearing electron-neutral, electron-withdrawing or electrondonating substitutions at the benzene ring proceeded well to give good yields ( Table 1 , entries [1] [2] [3] [4] [5] [6] [7] [8] [9] . The position of the substitution at benzene ring had little effect on the yield. The aryl methyl ketone with ortho group on the aromatic ring gave relatively lower yield (Table 1 , entry 4), which indicated that steric hindrance influenced the reaction negatively. Polycyclic aromatic methyl ketones like 1w and 1x were also viable substrates and afforded the corresponding products in comparable yields. When a range of heteroaromatic methyl ketones were employed as the substrates, the corresponding products were obtained in moderate yields (Table 2 , entries 10-16). Importantly, most products could precipitate from the solution with high purity, which made this process easy to be industrialized. It was a pity that no desired products were observed when 3-acetyl pyrrole (Table 2, entry 13) and 3-acetyl indole (Table  2 , entry 20) were employed as the substrates. It reflected that the DMSO oxidation of acetyl pyrrole was unworkable, which may have resulted from some side reactions such as nucleophilic attack at the pyrrole ring. It was reported that the 2,4 and 2,5 isomers of AAIs could be differentiated by NMR, but there were no statements on their analysis using HPLC. 28 We used different stationary phase such as ODS C18, pentafluorophenyl and β-cyclodextrin to analyze product 2k and 2k'. The results showed that compound 2k and 2k' coincided with each other to form a single chromatographic peak with high purity, which indicated that the two isomers of AAIs could not be separated by HPLC column. Furthermore, the products of substrates 1j and 1k were confirmed by X-ray crystallography (Figure 2 ). 31 The X-ray molecular structure revealed that the crystals of their products only had 2,4-isomers in solid form. This result confirmed the more stable configuration of AAI to be 2,4-isomer.
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In the procedure of synthesizing AAIs, we determined the main by-products of this process to be 2-hydroxy-3,6-diaryl-pyrazines. They could be precipitated from the solvents 24 hours later after AAIs' filtering. However, owing to the low solubility, it was very difficult to characterize all of them by NMR. The identified 2-hydroxy-3,6-diaryl-pyrazines were shown in Table 3 , others could be detected by HRMS as the isomers of their corresponding AAIs. Various conditions of the cascade procedure indicated that the yields of 2-hydroxy-3,6-diaryl-pyrazines increased with increasing temperature. The results suggested that this procedure was thermodynamically controlled. Furthermore, the yields of pyrazines were higher when ammonium acetate was used in the Debus condensation. In summary, aqueous ammonia and low temperature were beneficial to produce imidazoles, while ammonium acetate and high temperature were beneficial to produce pyrazines in this cascade process. The structure of product 3p was also confirmed by X-ray crystallography. 31 The bond length of the phenolic hydroxy was shorter than normal hydroxyl (1.41-1.44), being a medium between hydroxyl and carbonyl. Probably the hydroxy on 3p has a equilibrium between keto form and the enol form. Referring to the previous literature, 30 the possible mechanism for this procedure was illustrated with the example of acetophenone and aqueous ammonia (as shown in Scheme 2).
As to intermediate 13a, the electron doublet of N atom could attack carbonyl group 1 to form imidazole 1b and 1b' gradually (Scheme 2, route 1), and also could form pyrazine 1c by attacking carbonyl group 2 (Scheme 2, route 2). As the electropositivity of carbonyl group 1 was higher than carbonyl group 2, the main product was imidazole 1b and 1b'. However, with the rise of temperature, the probability of attacking carbonyl group 2 increased. That's why the yields of 2-hydroxy-3,6-diaryl-pyrazines increased with temperature.
Conclusions
In summary, we report a cascade procedure for the synthesis of (4 or 5)-aryl-2-aryloyl-1H-imidazoles and 2-hydroxy-3,6-diaryl-pyrazines from aryl methyl ketones. The mechanism was also conjectured. Owing to the simple starting materials, mild conditions, easy operation, high bioactivity of imidazole and pyrazine derivatives, this protocol not only meets the demand of commercial application, but also has great potential in medicinal chemistry.
Experimental Section
General. All reagents and solvents were purchased from J&K Chemical Co. and used without further purification. Melting points were determined on a SGW X-4 micro melting point instrument. 1 H and 13 C NMR spectra were recorded on Bruker 400 or 500 MHz spectrometer.
HPLC impurities were determined on a Shimadzu 10A chromatographic instrument. IR spectra were obtained on a Perkin Elmer FT-IR system. UV spectra were obtained on a TU-1810 ultraviolet visible spectrophotometer. HRMS spectra were obtained by a LTQ Orbitrap Discovery spectrometer from Thermo.
General procedure for the synthesis of compounds 2 1 mmol aryl methyl ketone and 1 mL aqueous HBr (48%) were mixed in 1 mL DMSO. The mixture was stirred at 55 °C for 10-12 h. After cooling in ice bath, aqueous ammonia (1 mL, 28%) was added to the solution. The mixture was stirred at 0-5 °C for 1 h. The obtained solid was filtered off to give AAI.
General procedure for the synthesis of compounds 3 1 mmol aryl methyl ketone and 1 mL aqueous HBr (48%) were mixed in 1 mL DMSO. The mixture was stirred at 55 °C for 10-12 h. After heating-up to 80 ºC, ammonium acetate (100 mg) was added to the solution. The mixture was stirred for 1 h. The obtained solid was filtered off. 2-Hydroxy-3,6-diarylpyrazine could be filtered from the filter liquor 24 hours later. 
Phenyl-(4-phenyl-1H-imidazol-2-yl)methanone (2a) and phenyl-(5-phenyl-1H-imidazol-2-yl)methanone (2a′

(3-Chlorophenyl)-[4-(3-chlorophenyl)-1H-imidazol-2-yl]methanone (2c) and (3-chlorophenyl)-[5-(3-chlorophenyl)-1H-imidazol-2-yl]methanone (2c′
Pyridin-2-yl-[4-(pyridin-2-yl)-1H-imidazol-2-yl]methanone (2j) and pyridin-2-yl-[5-(pyridin-2-yl)-1H-imidazol-2-yl]methanone (2j′
Pyridin-3-yl-[4-(pyridin-3-yl)-1H-imidazol-2-yl]methanone (2k) and pyridin-3-yl-[5-(pyridin-3-yl)-1H-imidazol-2-yl]methanone (2k′
Pyridin-4-yl-[4-(pyridin-4-yl)-1H-imidazol-2-yl]methanone (2l) and pyridin-4-yl-[5-(pyridin-4-yl)-1H-imidazol-2-yl]methanone (2l′
Thiophen-2-yl-[4-(thiophen-2-yl)-1H-imidazol-2-yl]methanone (2o) and thiophen-2-yl-[5-(thiophen-2-yl)-1H-imidazol-2-yl]methanone (2o′
Thiazol-2-yl-[4-(thiazol-2-yl)-1H-imidazol-2-yl]methanone (2p) and thiazol-2-yl(5-(thiazol-2-yl)-1H-imidazol-2-yl)methanone (2p′
Naphthalen-1-yl-[4-(naphthalen-1-yl)-1H-imidazol-2-yl]methanone (2q) and naphthalen-1-yl-[5-(naphthalen-1-yl)-1H-imidazol-2-yl]methanone (2q′
Quinolin-3-yl-[4-(quinolin-3-yl)-1H-imidazol-2-yl]methanone (2s) and quinolin-3-yl-[5-(quinolin-3-yl)-1H-imidazol-2-yl]methanone (2s′
